Clinical Trial

Improving Patient Safety by Supporting Older Adults in Managing Sleep Problems.

Study acronym: BE-SAFE
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
Among older adults (≥65 years), use of sleeping pills, such as benzodiazepines and other sedative-hypnotics, to treat sleep problems is common. While sleeping pills are effective in the first few weeks of use, their effect diminishes significantly after that. Especially older adults are susceptible to significant adverse effects of sleep pills, yet stopping sleeping pills remains challenging. BE-SAFE aims to conduct a randomised study testing a patient-centred intervention to reduce sleeping pill use and to improve patient safety and quality of care focusing on implementation aspects. The intervention addresses knowledge and practice gaps related to discontinuation of sleeping pills in older adults with sleep problems.
Protocol Amendment History 3 changes
critical Enrollment closed, study ongoing 2026-08-04
notable Primary completion pushed: 2026-02-01 -> 2027-07-31 2026-08-04
minor Completion pushed: 2026-02-01 -> 2027-07-31 2026-08-04
Trial Details
NCT Number NCT06584513
Lead Sponsor Insel Gruppe AG, University Hospital Bern
Collaborators: Universitat Autonoma de Barcelona, Oslo University Hospital, National and Kapodistrian University of Athens, Institute of Psychiatry and Neurology, Warsaw, Centre Hospitalier Universitaire UCLouvain Namur, Université Catholique de Louvain
Conditions Benzodiazepines Deprescribing, Sleep Problems
Enrollment 470 participants
Start Date 2024-11-18
Primary Completion 2027-07-31 (estimated)
Study Completion 2027-07-31 (estimated)
Updated on ClinicalTrials.gov 2026-08-03